MedTrace Logo

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

NCT00899262 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Collecting and storing samples of sputum and tissue to study in the laboratory may help doctors identify biomarkers related to cancer.

PURPOSE: This research study is looking samples of sputum and tissue from lung cancer patients, participants at high risk for developing lung cancer, and from healthy volunteers (both smokers and non-smokers).

Conditions

Interventions

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

sputum cytology

PROCEDURE

Fourier transform infrared spectroscopy

PROCEDURE

diagnostic bronchoscopy

Sponsors & Collaborators

  • South West Wales Cancer Institute

    lead OTHER

Principal Investigators

  • Paul D. Lewis, BSc, PhD · Swansea University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2011-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899262 on ClinicalTrials.gov